Reviewed,
UniProtKB/Swiss-Prot P01579 (IFNG_HUMAN)
Last modified
July 7, 2009.
Version 117.
History...
Clusters with 100%,
90%,
50% identity |
Documents (6) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Interferon gamma Short name=IFN-gamma Alternative name(s): Immune interferon | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Complete proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 166 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons. |
| Subunit structure | Homodimer. |
| Subcellular location | |
| Tissue specificity | Released primarily from activated T lymphocytes. |
| Post-translational modification | Proteolytic processing produces C-terminal heterogeneity, with proteins ending alternatively at Gly-150, Met-157 or Gly-161. |
| Involvement in disease | In Caucasians, genetic variation in IFNG is associated with the risk of aplastic anemia (AA) [MIM:609135]. AA is a rare disease in which the reduction of the circulating blood cells results from damage to the stem cell pool in bone marrow. In most patients, the stem cell lesion is caused by an autoimmune attack. T-lymphocytes, activated by an endogenous or exogenous, and most often unknown antigenic stimulus, secrete cytokines, including IFN-gamma, which would in turn be able to suppress hematopoiesis. |
| Pharmaceutical use | Available under the name Actimmune (Genentech). Used for reducing the frequency and severity of serious infections associated with chronic granulomatous disease (CGD). |
| Sequence similarities | Belongs to the type II (or gamma) interferon family. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 23 | 23 | Ref.8 Ref.9 | ||||||||||||||||||||||
| Chain | 24 – 161 | 138 | Interferon gamma | PRO_0000016444 | |||||||||||||||||||||
| Propeptide | 162 – 166 | 5 | PRO_0000259481 | ||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||
| Modified residue | 24 | 1 | Pyrrolidone carboxylic acid | ||||||||||||||||||||||
| Glycosylation | 48 | 1 | N-linked (GlcNAc...) Ref.8 | ||||||||||||||||||||||
| Glycosylation | 120 | 1 | N-linked (GlcNAc...); in dimeric form Ref.8 | ||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||
| Natural variant | 29 | 1 | K → Q | VAR_004017 | |||||||||||||||||||||
| Natural variant | 160 | 1 | R → Q | VAR_004018 | |||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||
| Helix | 2 – 18 | 17 | |||||||||||||||||||||||
| Helix | 25 – 38 | 14 | |||||||||||||||||||||||
| Helix | 53 – 58 | 6 | |||||||||||||||||||||||
| Helix | 62 – 81 | 20 | |||||||||||||||||||||||
| Turn | 82 – 85 | 4 | |||||||||||||||||||||||
| Turn | 87 – 89 | 3 | |||||||||||||||||||||||
| Helix | 90 – 104 | 15 | |||||||||||||||||||||||
| Helix | 109 – 119 | 11 | |||||||||||||||||||||||
| Helix | 126 – 140 | 15 | |||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Structure of the human immune interferon gene." Gray P.W., Goeddel D.V. Nature 298:859-863(1982) [PubMed: 6180322] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [2] | "Expression of human immune interferon cDNA in E. coli and monkey cells." Gray P.W., Leung D.W., Pennica D., Yelverton E., Najarian R., Simonsen C.C., Derynck R., Sherwood P.J., Wallace D.M., Berger S.L., Levinson A.D., Goeddel D.V. Nature 295:503-508(1982) [PubMed: 6173769] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [3] | "Cloning and expression of a novel variant of human interferon-gamma cDNA." Nishi T., Fujita T., Nishi-Takaoka C., Saito A., Matsumoto T., Sato M., Oka T., Itoh S., Yip Y.K., Vilcek J., Taniguchi T. J. Biochem. 97:153-159(1985) [PubMed: 2860101] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [4] | "Cloning and structure of the human immune interferon-gamma chromosomal gene." Taya Y., Devos R., Tavernier J., Cheroutre H., Engler G., Fiers W. EMBO J. 1:953-958(1982) [PubMed: 6329718] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [5] | "Molecular cloning of human immune interferon cDNA and its expression in eukaryotic cells." Devos R., Cheroutre H., Taya Y., Degrave W., van Heuverswyn H., Fiers W. Nucleic Acids Res. 10:2487-2501(1982) [PubMed: 6176945] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [6] | SeattleSNPs variation discovery resource Submitted (JUN-2001) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [7] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Blood. |
| [8] | "Natural human interferon-gamma. Complete amino acid sequence and determination of sites of glycosylation." Rinderknecht E., O'Conner B.H., Rodriguez H. J. Biol. Chem. 259:6790-6797(1984) [PubMed: 6427223] [Abstract] Cited for: PROTEIN SEQUENCE OF 24-157, GLYCOSYLATION AT ASN-48 AND ASN-120. |
| [9] | "Structural characterization of human interferon gamma. Heterogeneity of the carboxyl terminus." Pan Y.C.E., Stern A.S., Familletti P.C., Khan F.R., Chizzonite R. Eur. J. Biochem. 166:145-149(1987) [PubMed: 3109913] [Abstract] Cited for: PROTEIN SEQUENCE OF 24-161, PROTEOLYTIC PROCESSING OF THE C-TERMINUS. |
| [10] | "Studies on the sugar chains of interferon-gamma from human peripheral-blood lymphocytes." Yamamoto S., Hase S., Yamauchi H., Tanimoto T., Ikenaka T. J. Biochem. 105:1034-1039(1989) [PubMed: 2504704] [Abstract] Cited for: STRUCTURE OF CARBOHYDRATES. |
| [11] | "Three-dimensional structure of recombinant human interferon-gamma." Ealick S.E., Cook W.J., Vijay-Kumar S., Carson M., Nagabhushan T.L., Trotta P.P., Bugg C.E. Science 252:698-702(1991) [PubMed: 1902591] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (3.5 ANGSTROMS). |
| [12] | "Crystal structure of a complex between interferon-gamma and its soluble high-affinity receptor." Walter M.R., Windsor W.T., Nagabhushan T.L., Lundell D.J., Lunn C.A., Zauodny P.J., Narula S.K. Nature 376:230-235(1995) [PubMed: 7617032] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS). |
| [13] | "Design, characterization, and structure of a biologically active single-chain mutant of human IFN-gamma." Landar A., Curry B., Parker M.H., DiGiacomo R., Indelicato S.R., Nagabhushan T.L., Rizzi G., Walter M.R. J. Mol. Biol. 299:169-179(2000) [PubMed: 10860730] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS). |
| [14] | "Observation of an unexpected third receptor molecule in the crystal structure of human interferon-gamma receptor complex." Thiel D.J., le Du M.-H., Walter R.L., D'Arcy A., Chene C., Fountoulakis M., Garotta G., Winkler F.K., Ealick S.E. Structure 8:927-936(2000) [PubMed: 10986460] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF COMPLEX WITH RECEPTOR. |
| [15] | "1H, 13C, and 15N NMR backbone assignments and secondary structure of human interferon-gamma." Grzesiek S., Doebeli H., Gentz R., Garotta G., Labhardt A.M., Bax A. Biochemistry 31:8180-8190(1992) [PubMed: 1525157] [Abstract] Cited for: STRUCTURE BY NMR. |
| [16] | "Homozygosis for (12) CA repeats in the first intron of the human IFN-gamma gene is significantly associated with the risk of aplastic anaemia in Caucasian population." Dufour C., Capasso M., Svahn J., Marrone A., Haupt R., Bacigalupo A., Giordani L., Longoni D., Pillon M., Pistorio A., Di Michele P., Iori A.P., Pongiglione C., Lanciotti M., Iolascon A. Br. J. Haematol. 126:682-685(2004) [PubMed: 15327519] [Abstract] Cited for: ASSOCIATION WITH APLASTIC ANEMIA. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| X13274 mRNA. Translation: CAA31639.1. J00219 Genomic DNA. Translation: AAB59534.1. X01992 mRNA. Translation: CAA26022.1. V00543 mRNA. Translation: CAA23804.1. AF375790 Genomic DNA. Translation: AAK53058.1. BC070256 mRNA. Translation: AAH70256.1. | |||||||||||||||||||||||||||||||||||||
| IPI | IPI00307209. | ||||||||||||||||||||||||||||||||||||
| PIR | IVHUG. A93284. | ||||||||||||||||||||||||||||||||||||
| RefSeq | NP_000610.2. | ||||||||||||||||||||||||||||||||||||
| UniGene | Hs.856 | ||||||||||||||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||||||||||||||
| DIP | DIP:483N. | ||||||||||||||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||||||||||||||
| GlycoSuiteDB | P01579. | ||||||||||||||||||||||||||||||||||||
| PhosphoSite | P01579. | ||||||||||||||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||||||||||||||
| PRIDE | P01579. | ||||||||||||||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||||||||||||||
| Ensembl | ENSG00000111537. Homo sapiens. [Contig view] | ||||||||||||||||||||||||||||||||||||
| GeneID | 3458. | ||||||||||||||||||||||||||||||||||||
| KEGG | hsa:3458. | ||||||||||||||||||||||||||||||||||||
| UCSC | uc001stw.1. human. | ||||||||||||||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||||||||||||||
| GeneCards | GC12M066834. | ||||||||||||||||||||||||||||||||||||
| H-InvDB | HIX0036727. | ||||||||||||||||||||||||||||||||||||
| HGNC | HGNC:5438. IFNG. | ||||||||||||||||||||||||||||||||||||
| HPA | CAB010344. | ||||||||||||||||||||||||||||||||||||
| MIM | 147570. gene. 609135. phenotype. | ||||||||||||||||||||||||||||||||||||
| Orphanet | 88. Aplastic anemia. | ||||||||||||||||||||||||||||||||||||
| PharmGKB | PA29674. | ||||||||||||||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||||||||||||||
| HOGENOM | P01579. | ||||||||||||||||||||||||||||||||||||
| HOVERGEN | P01579. | ||||||||||||||||||||||||||||||||||||
| OMA | P01579. NWKEESD. | ||||||||||||||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||||||||||||||
| Pathway_Interaction_DB | nfat_tfpathway. Calcineurin-regulated NFAT-dependent transcription in lymphocytes. tcrcalciumpathway. Calcium signaling in the CD4+ TCR pathway. cd8tcrdownstreampathway. Downstream signaling in naive CD8+ T cells. ifngpathway. IFN-gamma pathway. il12_stat4pathway. IL12 signaling mediated by STAT4. il12_2pathway. IL12-mediated signaling events. il2_1pathway. IL2-mediated signaling events. il23pathway. IL23-mediated signaling events. il27pathway. IL27-mediated signaling events. pdgfrapathway. PDGFR-alpha signaling pathway. telomerasepathway. Regulation of Telomerase. | ||||||||||||||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||||||||||||||
| ArrayExpress | P01579. | ||||||||||||||||||||||||||||||||||||
| Bgee | P01579. | ||||||||||||||||||||||||||||||||||||
| CleanEx | HS_IFNG. | ||||||||||||||||||||||||||||||||||||
| GermOnline | ENSG00000111537. Homo sapiens. | ||||||||||||||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||||||||||||||
| InterPro | IPR012351. 4_helix_cytokine_core. IPR002069. Interferon_gamma. [Graphical view] | ||||||||||||||||||||||||||||||||||||
| Gene3D | G3DSA:1.20.1250.10. 4_helix_cytokine_core. 1 hit. | ||||||||||||||||||||||||||||||||||||
| PANTHER | PTHR11419. IFN-gamma. 1 hit. | ||||||||||||||||||||||||||||||||||||
| Pfam | PF00714. IFN-gamma. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||||||||
| PIRSF | PIRSF001936. IFN-gamma. 1 hit. | ||||||||||||||||||||||||||||||||||||
| ProDom | PD002435. IFN-gamma. 1 hit. [Graphical view] [Entries sharing at least one domain] | ||||||||||||||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||||||||||||||
Other Resources | |||||||||||||||||||||||||||||||||||||
| DrugBank | DB01296. Glucosamine. DB00033. Interferon gamma-1b. DB00641. Simvastatin. | ||||||||||||||||||||||||||||||||||||
| NextBio | 13624. | ||||||||||||||||||||||||||||||||||||
| PMAP-CutDB | P01579. | ||||||||||||||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||||||||||||||
Entry information
| Entry name | IFNG_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P01579 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| Human chromosome 12 Human chromosome 12: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with


